Gluten‑hydrolyzing probiotics: An emerging therapy for patients with celiac disease (Review)
- Authors:
- Devaraja Gayathri
- Alurappa Ramesha
-
Affiliations: Department of Microbiology, Davangere University, Davangere, Karnataka 577007, India - Published online on: June 19, 2020 https://doi.org/10.3892/wasj.2020.55
- Article Number: 14
-
Copyright: © Gayathri et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
|
Losowsky MS: A history of coeliac disease. Dig Dis. 26:112–120. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Dowd B and Walker-Smith J: Samuel Gee, Aretaeus, and the coeliac affection. BMJ. 2:45–47. 1974.PubMed/NCBI View Article : Google Scholar | |
|
Fasano A: Surprises from celiac disease. Sci Am. 301:54–61. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Dubé C, Rostom A, Sy R, Cranney A, Saloojee N, Garritty C, Sampson M, Zhang L, Yazdi F, Mamaladze V, et al: The prevalence of celiac disease in average-risk and at-risk Western European populations: A systematic review. Gastroenterology. 128 (Suppl 1):S57–S67. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Barada K, Bitar A, Mokadem MA, Hashash JG and Green P: Celiac disease in Middle Eastern and North African countries: A new burden? World J Gastroenterol. 16:1449–1457. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Yadav P, Das P, Mirdha BR, Gupta SD, Bhatnagar S, Pandey RM and Makharia GK: Current spectrum of malabsorption syndrome in adults in India. Indian J Gastroenterol. 30:22–28. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, Elitsur Y, Green PH, Guandalini S, Hill ID, et al: Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: A large multicenter study. Arch Intern Med. 163:286–292. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Mohindra S, Yachha SK, Srivastava A, Krishnani N, Aggarwal R, Ghoshal UC, Prasad KK and Naik SR: Coeliac disease in Indian children: Assessment of clinical, nutritional and pathologic characteristics. J Health Popul Nutr. 19:204–208. 2001.PubMed/NCBI | |
|
Sollid LM: Molecular basis of celiac disease. Annu Rev Immunol. 18:53–81. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Korponay-Szabó IR, Halttunen T, Szalai Z, Laurila K, Király R, Kovács JB, Fésüs L and Mäki M: In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut. 53:641–648. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Ivarsson A, Hernell O, Stenlund H and Persson LA: Breast-feeding protects against celiac disease. Am J Clin Nutr. 75:914–921. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Chander AM, Yadav H, Jain S, Bhadada SK and Dhawan DK: Cross-talk between gluten, intestinal microbiota and intestinal mucosa in celiac disease: Recent advances and basis of autoimmunity. Front Microbiol. 9(2597)2018.PubMed/NCBI View Article : Google Scholar | |
|
Rastogi A, Bhadada SK, Bhansali A, Kochhar R and Santosh R: Celiac disease: A missed cause of metabolic bone disease. Indian J Endocrinol Metab. 16:780–785. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Howard MR, Turnbull AJ, Morley P, Hollier P, Webb R and Clarke A: A prospective study of the prevalence of undiagnosed coeliac disease in laboratory defined iron and folate deficiency. J Clin Pathol. 55:754–757. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Rostom A, Murray JA and Kagnoff MF: American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 131:1981–2002. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Annibale B, Lahner E, Chistolini A, Gailucci C, Di Giulio E, Capurso G, Luana O, Monarca B and Delle Fave G: Endoscopic evaluation of the upper gastrointestinal tract is worthwhile in premenopausal women with iron deficiency anaemia irrespective of menstrual flow. Scand J Gastroenterol. 38:239–245. 2003.PubMed/NCBI | |
|
Ludvigsson JF, Osby U, Ekbom A and Montgomery SM: Coeliac disease and risk of schizophrenia and other psychosis: A general population cohort study. Scand J Gastroenterol. 42:179–185. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Gayathri D and Rashmi BS: Development of celiac disease; pathogenesis and strategies to control: A molecular approach. J Nutr Food Sci. 4(310)2014. | |
|
Coqueiro AY, Bonvini A, Tirapegui J and Rogero MM: Probiotics supplementation as an alternative method for celiac disease treatment. Int J Probiotics Prebiotics. 12:23–32. 2017. | |
|
Högberg L, Fälth-Magnusson K, Grodzinsky E and Stenhammar L: Familial prevalence of coeliac disease: A twenty-year follow-up study. Scand J Gastroenterol. 38:61–65. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Hill ID: Management of celiac disease in childhood and adolescence: Unique challenges and strategies. Curr Treat Options Gastroenterol. 9:399–408. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Ludvigsson JF, Fälth-Magnusson K and Ludvigsson J: Tissue transglutaminase auto-antibodies in cord blood from children to become celiacs. Scand J Gastroenterol. 36:1279–1283. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F and Thorsby E: Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med. 169:345–350. 1989.PubMed/NCBI View Article : Google Scholar | |
|
Kaur G, Sarkar N, Bhatnagar S, Kumar S, Rapthap CC, Bhan MK and Mehra NK: Pediatric celiac disease in India is associated with multiple DR3-DQ2 haplotypes. Hum Immunol. 63:677–682. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Megiorni F and Pizzuti A: HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: Practical implications of the HLA molecular typing. J Biomed Sci. 19(88)2012.PubMed/NCBI View Article : Google Scholar | |
|
van de Wal Y, Kooy YM, van Veelen P, Vader W, August SA, Drijfhout JW, Peña SA and Koning F: Glutenin is involved in the gluten-driven mucosal T cell response. Eur J Immunol. 29:3133–3139. 1999.PubMed/NCBI View Article : Google Scholar | |
|
Molberg O, Kett K, Scott H, Thorsby E, Sollid LM and Lundin KE: Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand J Immunol. 46:103–109. 1997.PubMed/NCBI View Article : Google Scholar | |
|
Arentz-Hansen H, Körner R, Molberg O, Quarsten H, Vader W, Kooy YM, Lundin KE, Koning F, Roepstorff P, Sollid LM, et al: The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med. 191:603–612. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Visser J, Rozing J, Sapone A, Lammers K and Fasano A: Tight junctions, intestinal permeability, and autoimmunity: Celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci. 1165:195–205. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Ráki M, Schjetne KW, Stamnaes J, Molberg Ø, Jahnsen FL, Issekutz TB, Bogen B and Sollid LM: Surface expression of transglutaminase 2 by dendritic cells and its potential role for uptake and presentation of gluten peptides to T cells. Scand J Immunol. 65:213–220. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Manavalan JS, Hernandez L, Shah JG, Konikkara J, Naiyer AJ, Lee AR, Ciaccio E, Minaya MT, Green PH and Bhagat G: Serum cytokine elevations in celiac disease: Association with disease presentation. Hum Immunol. 71:50–57. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Xu H, Feely SL, Wang X, Liu DX, Borda JT, Dufour J, Li W, Aye PP, Doxiadis GG, Khosla C, et al: Gluten-sensitive enteropathy coincides with decreased capability of intestinal T cells to secrete IL-17 and IL-22 in a macaque model for celiac disease. Clin Immunol. 147:40–49. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Husby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips A, Shamir R, Troncone R, Giersiepen K, Branski D, Catassi C, et al: ESPGHAN Working Group on Coeliac Disease Diagnosis; ESPGHAN Gastroenterology Committee; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition: European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 54:136–160. 2012. | |
|
Fasano A, Araya M, Bhatnagar S, Cameron D, Catassi C, Dirks M, Mearin ML, Ortigosa L and Phillips A: Celiac Disease Working Group, FISPGHAN. Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition consensus report on celiac disease. J Pediatr Gastroenterol Nutr. 47:214–219. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Ciacci C, Maiuri L, Russo I, Tortora R, Bucci C, Cappello C, Santonicola A, Luciani A, Passananti V and Iovino P: Efficacy of budesonide therapy in the early phase of treatment of adult coeliac disease patients with malabsorption: An in vivo/in vitro pilot study. Clin Exp Pharmacol Physiol. 36:1170–1176. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Liang L, Pinier M, Leroux JC and Subirade M: Interaction of alpha-gliadin with poly(HEMA-co-SS): Structural characterization and biological implication. Biopolymers. 91:169–178. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Dieterich W, Trapp D, Esslinger B, Leidenberger M, Piper J, Hahn E and Schuppan D: Autoantibodies of patients with coeliac disease are insufficient to block tissue transglutaminase activity. Gut. 52:1562–1566. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Goerres MS, Meijer JW, Wahab PJ, Kerckhaert JA, Groenen PJ, Van Krieken JH and Mulder CJ: Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther. 18:487–494. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Pinier M, Fuhrmann G, Galipeau HJ, Rivard N, Murray JA, David CS, Drasarova H, Tuckova L, Leroux JC and Verdu EF: The copolymer P(HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues. Gastroenterology. 142:316–25.e1, 12. 2012.PubMed/NCBI View Article : Google Scholar | |
|
De Angelis M, Cassone A, Rizzello CG, Gagliardi F, Minervini F, Calasso M, Di Cagno R, Francavilla R and Gobbetti M: Mechanism of degradation of immunogenic gluten epitopes from Triticum turgidum L. var. durum by sourdough lactobacilli and fungal proteases. Appl Environ Microbiol. 76:508–518. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Gass J, Ehren J, Strohmeier G, Isaacs I and Khosla C: Fermentation, purification, formulation, and pharmacological evaluation of a prolyl endopeptidase from Myxococcus xanthus: Implications for Celiac Sprue therapy. Biotechnol Bioeng. 92:674–684. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Hallert C, Grant C, Grehn S, Grännö C, Hultén S, Midhagen G, Ström M, Svensson H and Valdimarsson T: Evidence of poor vitamin status in coeliac patients on a gluten-free diet for 10 years. Aliment Pharmacol Ther. 16:1333–1339. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Asha and Gayathri D: Synergistic impact of Lactobacillus fermentum, Lactobacillus plantarum and vincristine on 1,2-dimethylhydrazine-induced colorectal carcinogenesis in mice. Exp Ther Med. 3:1049–1054. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Gayathri D, Asha and Devaraja TN: Lactobacillus sp. as probiotics for human health with special emphasis on colorectal cancer. Indian J Sci Technol. 4:1008–1014. 2011. | |
|
Quigley EMM: Gut bacteria in health and disease. Gastroenterol Hepatol (N Y). 9:560–569. 2013.PubMed/NCBI | |
|
Patel RM and Lin PW: Developmental biology of gut-probiotic interaction. Gut Microbes. 1:186–195. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Lebeer S, Vanderleyden J and De Keersmaecker SC: Host interactions of probiotic bacterial surface molecules: Comparison with commensals and pathogens. Nat Rev Microbiol. 8:171–184. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Pagnini C, Saeed R, Bamias G, Arseneau KO, Pizarro TT and Cominelli F: Probiotics promote gut health through stimulation of epithelial innate immunity. Proc Natl Acad Sci USA. 107:454–459. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Corr SC, Li Y, Riedel CU, O'Toole PW, Hill C and Gahan CG: Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci USA. 104:7617–7621. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Metchnikoff E: The nature of man. Studies in optimistic philosophy. William Heinemann, London, 1908. | |
|
Fuller R: Probiotics in man and animals. J Appl Bacteriol. 66:365–378. 1989.PubMed/NCBI | |
|
Havenaar R, Brink T and Huis in't Veld JHJ: Selection of Strains for Probiotic Use. In: Probiotics: The Scientific Basis. Fuller R (ed). Chapman & Hall, London, pp151-170, 1992. | |
|
Salminen S, Ouwehand A, Benno Y and Lee YK: Probiotics: How should they be defined. Trends Food Sci Technol. 10:107–110. 1999. | |
|
Khatri I, Sharma S, Ramya TNC and Subramanian S: Complete genomes of Bacillus coagulans S-lac and Bacillus subtilis TO-A JPC, two phylogenetically distinct probiotics. PLoS One. 11(e0156745)2016.PubMed/NCBI View Article : Google Scholar | |
|
Isolauri E, Salminen S and Ouwehand AC: Microbial-gut interactions in health and diseasein infective diarrhoea and inflammatory bowel diseases. J Gastroenterol Hepatol. 15:489–493. 2000. | |
|
Loponen J: Prolamin degradation in sourdoughs(unpublished PhD thesis). University of Helsinki, 2006. | |
|
Piper JL, Gray GM and Khosla C: Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo. J Pharmacol Exp Ther. 311:213–219. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Hausch F, Shan L, Santiago NA, Gray GM and Khosla C: Intestinal digestive resistance of immunodominant gliadin peptides. Am J Physiol Gastrointest Liver Physiol. 283:G996–G1003. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Tye-Din JA, Anderson RP, Ffrench RA, Brown GJ, Hodsman P, Siegel M, Botwick W and Shreeniwas R: The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo. Clin Immunol. 134:289–295. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Shan L, Marti T, Sollid LM, Gray GM and Khosla C: Comparative biochemical analysis of three bacterial prolyl endopeptidases: Implications for coeliac sprue. Biochem J. 383:311–318. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Pyle GG, Paaso B, Anderson BE, Allen DD, Marti T, Li Q, Siegel M, Khosla C and Gray GM: Effect of pretreatment of food gluten with prolyl endopeptidase on gluten-induced malabsorption in celiac sprue. Clin Gastroenterol Hepatol. 3:687–694. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Chen YS, Christensen JE, Broadbent JR and Steele JL: Identification and characterization of Lactobacillus helveticus PepO2, an endopeptidase with post-proline specificity. Appl Environ Microbiol. 69:1276–1282. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Rashmi BS and Gayathri D: Draft genome sequence of gluten hydrolysing bacterium Bacillus subtilis GS 188, Isolated from Wheat Sourdough. Genome Announc. 5(e00952)2017.PubMed/NCBI View Article : Google Scholar | |
|
Rashmi BS and Gayathri D: Molecular characterization of gluten hydrolysing Bacillus sp and their efficacy and biotherapeutic potential as probiotics using Caco-2 cell line. J Appl Microbiol. 123:759–772. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Stepniak D, Spaenij-Dekking L, Mitea C, Moester M, de Ru A, Baak-Pablo R, van Veelen P, Edens L and Koning F: Highly efficient gluten degradation with a newly identified prolyl endoprotease: Implications for celiac disease. Am J Physiol Gastrointest Liver Physiol. 291:G621–G629. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Edens L, Dekker P, van der Hoeven R, Deen F, de Roos A and Floris R: Extracellular prolyl endoprotease from Aspergillus niger and its use in the debittering of protein hydrolysates. J Agric Food Chem. 53:7950–7957. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Di Cagno R, De Angelis M, Lavermicocca P, De Vincenzi M, Giovannini C, Faccia M and Gobbetti M: Proteolysis by sourdough lactic acid bacteria: Effects on wheat flour protein fractions and gliadin peptides involved in human cereal intolerance. Appl Environ Microbiol. 68:623–633. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Gobbetti M, Cagno RD and De Angelis M: Functional microorganisms for functional food quality. Crit Rev Food Sci Nutr. 50:716–727. 2010.PubMed/NCBI View Article : Google Scholar | |
|
di Cagno R, de Angelis M, Alfonsi G, de Vincenzi M, Silano M, Vincentini O and Gobbetti M: Pasta made from durum wheat semolina fermented with selected lactobacilli as a tool for a potential decrease of the gluten intolerance. J Agric Food Chem. 53:4393–4402. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Rizzello CG, De Angelis M, Di Cagno R, Camarca A, Silano M, Losito I, De Vincenzi M, De Bari MD, Palmisano F, Maurano F, et al: Highly efficient gluten degradation by lactobacilli and fungal proteases during food processing: New perspectives for celiac disease. Appl Environ Microbiol. 73:4499–4507. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Dekking EHA, Veelen PAV, de Ru A, Kooy-Winkelaar EMC and Groneveld T: Microbial transglutaminases generate T cell stimulatory epitopes involved in celiac disease. J Cereal Sci. 47:339–346. 2008. | |
|
de Sousa Moraes LF, Grzeskowiak LM, de Sales Teixeira TF and Gouveia Peluzio MC: Intestinal microbiota and probiotics in celiac disease. Clin Microbiol Rev. 27:482–489. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Ohland CL and Macnaughton WK: Probiotic bacteria and intestinal epithelial barrier function. Am J Physiol Gastrointest Liver Physiol. 298:G807–G819. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Sartor RB: Mechanisms of disease: Pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 3:390–407. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Anderson RC, Cookson AL, McNabb WC, Park Z, McCann MJ, Kelly WJ and Roy NC: Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression l. Probiotics. Best Pract Res Clin Gastroenterol. 18:299–313. 2004. | |
|
O'Shea EF, Cotter PD, Stanton C, Ross RP and Hill C: Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: Bacteriocins and conjugated linoleic acid. Int J Food Microbiol. 152:189–205. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Thomas CM and Versalovic J: Probiotics-host communication: Modulation of signaling pathways in the intestine. Gut Microbes. 1:148–163. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Boirivant M and Strober W: The mechanism of action of probiotics. Curr Opin Gastroenterol. 23:679–692. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Gionchetti P, Rizzello F, Venturi A and Campieri M: Probiotics evels of genes involved in tight junction formation. BMC Microbiol. 10(316)2010.PubMed/NCBI View Article : Google Scholar | |
|
Hummel S, Veltman K, Cichon C, Sonnenborn U and Schmidt MA: Differential targeting of the E-Cadherin/β-Catenin complex by gram-positive probiotic lactobacilli improves epithelial barrier function. Appl Environ Microbiol. 78:1140–1147. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Zyrek AA, Cichon C, Helms S, Enders C, Sonnenborn U and Schmidt MA: Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol. 9:804–816. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Dai C, Zhao DH and Jiang M: VSL#3 probiotics regulate the intestinal epithelial barrier in vivo and in vitro via the p38 and ERK signaling pathways. Int J Mol Med. 29:202–208. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Ouwehand AC, Salminen S, Tölkkö S, Roberts P, Ovaska J and Salminen E: Resected human colonic tissue: New model for characterizing adhesion of lactic acid bacteria. Clin Diagn Lab Immunol. 9:184–186. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Vélez MP, De Keersmaecker SC and Vanderleyden J: Adherence factors of Lactobacillus in the human gastrointestinal tract. FEMS Microbiol Lett. 276:140–148. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Buck BL, Altermann E, Svingerud T and Klaenhammer TR: Functional analysis of putative adhesion factors in Lactobacillus acidophilus NCFM. Appl Environ Microbiol. 71:8344–8351. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Sánchez B, Urdaci MC and Margolles A: Extracellular proteins secreted by probiotic bacteria as mediators of effects that promote mucosa-bacteria interactions. Microbiology. 156:3232–3242. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Juntunen M, Kirjavainen PV, Ouwehand AC, Salminen SJ and Isolauri E: Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection. Clin Diagn Lab Immunol. 8:293–296. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Coconnier MH, Bernet MF, Chauvière G and Servin AL: Adhering heat-killed human Lactobacillus acidophilus, strain LB, inhibits the process of pathogenicity of diarrhoeagenic bacteria in cultured human intestinal cells. J Diarrhoeal Dis Res. 11:235–242. 1993.PubMed/NCBI | |
|
Greenberg B: Salmonella suppression by known populations of bacteria in flies. J Bacteriol. 99:629–635. 1969.PubMed/NCBI | |
|
Schiffrin EJ and Blum S: Interactions between the microbiota and the intestinal mucosa. Eur J Clin Nutr. 56 (Suppl 3):S60–S64. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Khani S, Motamedifar M, Golmoghaddam H, Hosseini HM and Hashemizadeh Z: In vitro study of the effect of a probiotic bacterium Lactobacillus rhamnosus against herpes simplex virus type 1. Braz J Infect Dis. 16:129–135. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Ahmad K, Fatemeh F, Mehri N and Maryam S: Probiotics for the treatment of pediatric Helicobacter pylori infection: A randomized double blind clinical trial. Iran J Pediatr. 23:79–84. 2013.PubMed/NCBI | |
|
De Keersmaecker SC, Verhoeven TL, Desair J, Marchal K, Vanderleyden J and Nagy I: Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella typhimurium is due to accumulation of lactic acid. FEMS Microbiol Lett. 259:89–96. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Hassan M, Kjos M, Nes IF, Diep DB and Lotfipour F: Natural antimicrobial peptides from bacteria: Characteristics and potential applications to fight against antibiotic resistance. J Appl Microbiol. 113:723–736. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Bierbaum G and Sahl HG: Lantibiotics: Mode of action, biosynthesis and bioengineering. Curr Pharm Biotechnol. 10:2–18. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Coloretti F, Carri S, Armaforte E, Chiavari C, Grazia L and Zambonelli C: Antifungal activity of lactobacilli isolated from salami. FEMS Microbiol Lett. 271:245–250. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Prema P, Smila D, Palavesam A and Immanuel G: Production and characterization of an antifungal compound (3-phenyllactic acid) produced by Lactobacillus plantarum strain. Food Bioprocess Technol. 3:379–386. 2008. | |
|
Magnusson J and Schnürer J: Lactobacillus coryniformis subsp. coryniformis strain Si3 produces a broad-spectrum proteinaceous antifungal compound. Appl Environ Microbiol. 67:1–5. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Dal Bello F, Clarke CI, Ryan LAM, Ulmer H, Schober TJ, Ström K, Sjögren J, van Sinderen D, Schnürer J and Arendt EK: Improvement of the quality and shelf life of wheat bread by fermentation with the antifungal strain Lactobacillus plantarum FST 1.7. J Cereal Sci. 45:309–318. 2007. | |
|
Ström K, Sjögren J, Broberg A and Schnürer J: Lactobacillus plantarum MiLAB 393 produces the antifungal cyclic dipeptides cyclo(L-Phe-L-Pro) and cyclo(L-Phe-trans-4-OH-L-Pro) and 3-phenyllactic acid. Appl Environ Microbiol. 68:4322–4327. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Gómez-Llorente C, Muñoz S and Gil A: Role of Toll-like receptors in the development of immunotolerance mediated by probiotics. Proc Nutr Soc. 69:381–389. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Wells JM: Immunomodulatory mechanisms of lactobacilli. Microb Cell Fact. 10 (Suppl 1)(S17)2011.PubMed/NCBI View Article : Google Scholar | |
|
Vizoso Pinto MG, Rodriguez Gómez M, Seifert S, Watzl B, Holzapfel WH and Franz CM: Lactobacilli stimulate the innate immune response and modulate the TLR expression of HT29 intestinal epithelial cells in vitro. Int J Food Microbiol. 133:86–93. 2009.PubMed/NCBI View Article : Google Scholar | |
|
D'Angelo C, Reale M and Costantini E: Microbiota and Lnd HIV infection. Nutrients. 9(615)2017. | |
|
Sharma P, Tomar SK, Goswami P, Sangwan SR and Singh R: Antibiotic resistance among commercially available probiotics. Food Res Int. 57:176–195. 2014. | |
|
Sorokulova IB, Pinchuk IV, Denayrolles M, Osipova IG, Huang JM, Cutting SM and Urdaci MC: The safety of two Bacillus probiotic strains for human use. Dig Dis Sci. 53:954–963. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Sanders ME, Akkermans LM, Haller D, Hammerman C, Heimbach J, Hörmannsperger G, Huys G, Levy DD, Lutgendorff F, Mack D, et al: Safety assessment of probiotics for human use. Gut Microbes. 1:164–185. 2010.PubMed/NCBI View Article : Google Scholar | |
|
McFarland LV and Dublin S: Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol. 14:2650–2661. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Finegold SM, Sutter VL and Mathisen GE: Normal indigenous intestinal flora. In: Human Intestinal Microflora in Health and Disease. Hentiges DJ (ed). Academic Press, New York, NY, 1983. | |
|
Didari T, Solki S, Mozaffari S, Nikfar S and Abdollahi M: A systematic review of the safety of probiotics. Expert Opin Drug Saf. 13:227–239. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Hong HA, Duc H and Cutting SM: The use of bacterial spore formers as probiotics. FEMS Microbiol Rev. 29:813–835. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Cutting SM: Bacillus probiotics. Food Microbiol. 28:214–220. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Hoa NT, Baccigalupi L, Huxham A, Smertenko A, Van PH, Ammendola S, Ricca E and Cutting AS: Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders. Appl Environ Microbiol. 66:5241–5247. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Sonenshein AL, Hoch JA and Losick R: Bacillus subtilis and other gram-positive bacteria: biochemistry, physiology, and molecular genetics. American Society for Microbiology, Washington, DC, 1993. | |
|
Zhang JL, Xie QM, Ji J, Yang WH, Wu YB, Li C, Ma JY and Bi YZ: Different combinations of probiotics improve the production performance, egg quality, and immune response of layer hens. Poult Sci. 91:2755–2760. 2012.PubMed/NCBI View Article : Google Scholar | |
|
van der Aa Kühle A, Skovgaard K and Jespersen L: In vitro screening of probiotic properties of Saccharomyces cerevisiae var. boulardii and food-borne Saccharomyces cerevisiae strains. Int J Food Microbiol. 101:29–39. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Czerucka D, Piche T and Rampal P: Review article: Yeast as probiotics -Saccharomyces boulardii. Aliment Pharmacol Ther. 26:767–778. 2007.PubMed/NCBI View Article : Google Scholar |
